Maxine S. Emmett
Affiliations: | 2004-2008 | Department of Physiology | University of Bristol, Bristol, England, United Kingdom |
Google:
"Maxine Emmett"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alghanem AF, Wilkinson EL, Emmett MS, et al. (2017) RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells. Angiogenesis |
| Wilkie MD, Emmett MS, Santosh S, et al. (2014) Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck. Head & Neck |
| Dewing D, Emmett M, Pritchard Jones R. (2012) The Roles of Angiogenesis in Malignant Melanoma: Trends in Basic Science Research over the Last 100 Years. Isrn Oncology. 2012: 546927 |
| Wilkie M, Santosh S, Emmett M, et al. (2012) Expression of total vascular endothelial growth factor (VEGF) and inhibitory isoforms of VEGF in head and neck squamous cell carcinoma International Journal of Surgery. 10: S2 |
| Emmett MS, Lanati S, Dunn DB, et al. (2011) CCR7 mediates directed growth of melanomas towards lymphatics. Microcirculation (New York, N.Y. : 1994). 18: 172-82 |
| Lanati S, Dunn DB, Roussigné M, et al. (2010) Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo. Cancer Research. 70: 8138-48 |
| Emmett MS, Symonds KE, Rigby H, et al. (2010) Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. Bmc Cancer. 10: 208 |
| Shields JD, Emmett MS, Dunn DB, et al. (2007) Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene. 26: 2997-3005 |
| Foster RR, Satchell SC, Seckley J, et al. (2006) VEGF-C promotes survival in podocytes American Journal of Physiology - Renal Physiology. 291 |
| Fiedler U, Christian S, Koidl S, et al. (2006) The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors American Journal of Pathology. 168: 1045-1053 |